These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8533671)

  • 1. [Change in serum prostate specific antigen values in men who had no evidence of prostate cancer on initial biopsy].
    Miyamoto S; Jimbo H; Totsuka Y; Mashimo T; Umeyama T; Uehara H; Shinozaki T
    Hinyokika Kiyo; 1995 Oct; 41(10):767-70. PubMed ID: 8533671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PSA and its indices in determining the need for repeat prostate biopsies.
    Ukimura O; Durrani O; Babaian RJ
    Urology; 1997 Jul; 50(1):66-72. PubMed ID: 9218021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).
    Roobol MJ; van der Cruijsen IW; Schröder FH
    Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study.
    Yang WJ; Lee DH; Chung BH; Cho JS; Choi YD; Kim SJ; Cho IR; Kim HS; Kim CI; Hong SJ;
    Urology; 2006 Feb; 67(2):333-6. PubMed ID: 16461083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.
    Pinsky PF; Crawford ED; Kramer BS; Andriole GL; Gelmann EP; Grubb R; Greenlee R; Gohagan JK
    BJU Int; 2007 Apr; 99(4):775-9. PubMed ID: 17223921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in patterns of practice in diagnosing screen-detected prostate cancer.
    Nam RK; Toi A; Trachtenberg J; Jewett MA; Klotz L; Fleshner N; Bagnell PS; Sweet J; Sugar L; Narod SA
    BJU Int; 2004 Dec; 94(9):1239-44. PubMed ID: 15610097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.
    Djavan B; Fong YK; Ravery V; Remzi M; Horninger W; Susani M; Kreuzer S; Boccon-Gibod L; Bartsch G; Marberger M
    Eur Urol; 2005 Jan; 47(1):38-44; discussion 44. PubMed ID: 15582247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
    Freedland SJ; Mangold LA; Epstein JI; Partin AW
    Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.
    Fowler JE; Bigler SA; Miles D; Yalkut DA
    J Urol; 2000 Mar; 163(3):813-8. PubMed ID: 10687983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
    Raaijmakers R; Wildhagen MF; Ito K; Pàez A; de Vries SH; Roobol MJ; Schröder FH
    Urology; 2004 Feb; 63(2):316-20. PubMed ID: 14972481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels.
    Perachino M; di Ciolo L; Barbetti V; Ardoino S; Vitali A; Introini C; Vigliercio G; Puppo P
    Eur Urol; 1997; 32(2):155-9. PubMed ID: 9286645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.
    Berger AP; Deibl M; Steiner H; Bektic J; Pelzer A; Spranger R; Klocker H; Bartsch G; Horninger W
    Prostate; 2005 Aug; 64(3):240-5. PubMed ID: 15712213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
    Macefield RC; Lane JA; Metcalfe C; Down L; Neal DE; Hamdy FC; Donovan JL
    Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long follow-up on prostate specific antigen density and prostate biopsy.
    Netto Júnior NR; De Lima ML; Lavoura Júnior Nda S; Apuzzo F; De Lucena RG
    Arch Esp Urol; 1998 Dec; 51(10):1050-3. PubMed ID: 9951132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.
    Eggener SE; Roehl KA; Catalona WJ
    J Urol; 2005 Aug; 174(2):500-4. PubMed ID: 16006880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.